Neptune Technologies & Bioresources Inc Total Assets 2009-2019 | NEPT

Neptune Technologies & Bioresources Inc total assets from 2009 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Neptune Technologies & Bioresources Inc Annual Total Assets
(Millions of US $)
2019 $69
2018 $77
2016 $81
2015 $81
2015 $0
2014 $98
2014 $0
2013 $68
2013 $0
2012 $45
2012 $0
2011 $23
2011 $0
2010 $16
2010 $0
2009 $16
2009 $0
Neptune Technologies & Bioresources Inc Quarterly Total Assets
(Millions of US $)
Q1 2019 $65
Q4 2019 $69
Q3 2018 $70
Q2 2018 $75
Q1 2018 $74
Q3 2016 $83
Q2 2016 $75
Q1 2016 $76
Q4 2016 $76
Q4 2016 $0
Q3 2015 $66
Q2 2015 $70
Q1 2015 $75
Q4 2015 $88
Q3 2014 $99
Q2 2014 $109
Q1 2014 $116
Q4 2014 $98
Q3 2013 $61
Q2 2013 $65
Q1 2013 $64
Q4 2013 $68
Q4 2013 $0
Q3 2012 $76
Q2 2012 $49
Q1 2012 $49
Q4 2012 $45
Q3 2011 $39
Q2 2011 $36
Q1 2011 $35
Q4 2011 $23
Q3 2010 $23
Q2 2010 $19
Q1 2010 $19
Q4 2010 $16
Q3 2009 $16
Q2 2009 $15
Q1 2009 $15
Q4 2009 $16
Q3 2008 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.317B $0.018B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $144.308B 26.34
Medtronic (MDT) Ireland $143.049B 20.08
Stryker (SYK) United States $80.458B 27.82
Boston Scientific (BSX) United States $53.838B 26.11
Baxter (BAX) United States $45.159B 27.38
EssilorLuxottica Societe Anonyme (ESLOY) France $32.445B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.251B 18.08
Coloplast (CLPBY) Denmark $25.596B 40.86
Lonza Group Ag (LZAGY) Switzerland $25.453B 0.00
Terumo (TRUMY) Japan $24.836B 31.00
Smith & Nephew SNATS (SNN) United Kingdom $19.091B 0.00
ResMed (RMD) United States $18.765B 35.76
Sunny Optical Technology (SNPTF) China $16.387B 0.00
Bio-Rad Laboratories (BIO) United States $10.297B 55.20
Insulet (PODD) United States $9.275B 549.57
Perrigo (PRGO) Ireland $7.335B 13.51
Canopy Growth (CGC) Canada $7.079B 0.00
Hill-Rom Holdings (HRC) United States $6.788B 20.24
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.231B 27.02
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.753B 0.00
NuVasive (NUVA) United States $3.507B 27.96
Neogen (NEOG) United States $3.413B 57.10
ICU Medical (ICUI) United States $3.189B 20.69
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.674B 0.00
Quidel (QDEL) United States $2.537B 25.19
Agios Pharmaceuticals (AGIO) United States $1.964B 0.00
National Vision Holdings (EYE) United States $1.818B 39.24
Cardiovascular Systems (CSII) United States $1.698B 0.00
Aphria (APHA) $1.215B 0.00
VAREX IMAGING (VREX) United States $1.119B 25.79
AtriCure (ATRC) United States $1.026B 0.00
Phibro Animal Health (PAHC) United States $0.871B 14.17
Eagle Pharmaceuticals (EGRX) United States $0.852B 21.73
Omeros (OMER) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.752B 0.00
PetIQ (PETQ) United States $0.731B 17.26
Lantheus Holdings (LNTH) United States $0.722B 18.97
LeMaitre Vascular (LMAT) United States $0.707B 41.91
Cerus (CERS) United States $0.630B 0.00
Surmodics (SRDX) United States $0.603B 114.61
MacroGenics (MGNX) United States $0.556B 0.00
TG Therapeutics (TGTX) United States $0.524B 0.00
OraSure Technologies (OSUR) United States $0.505B 23.37
Quanterix (QTRX) United States $0.500B 0.00
Owens & Minor (OMI) United States $0.455B 13.64
Meridian Bioscience (VIVO) United States $0.426B 13.31
Utah Medical Products (UTMD) United States $0.365B 26.75
Zynex (ZYXI) United States $0.353B 37.52
BioLife Solutions (BLFS) United States $0.344B 105.56
United Health Products (UEEC) United States $0.233B 0.00
Bovie Medical (APYX) United States $0.230B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.162B 0.00
Cytosorbents (CTSO) United States $0.151B 0.00
Female Health (VERU) United States $0.133B 0.00
Fonar (FONR) United States $0.131B 9.17
InfuSystems Holdings (INFU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) Canada $0.111B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.086B 20.37
Nephros (NEPH) United States $0.075B 0.00
MTech Acquisition (KERN) United States $0.060B 0.00
MRI Interventions (MRIC) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.038B 0.00
Senestech (SNES) United States $0.022B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00